Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07663786
Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
This study uses existing cancer registry and health record data to understand how nivolumab is used in routine care in the Netherlands for adults with advanced cancers of the esophagus, gastroesophageal junction, or stomach.
Official title: ENDURANCE: Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Dutch Daily Clinical Practice. Part B1
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
726
Start Date
2025-10-09
Completion Date
2027-02-01
Last Updated
2026-06-23
Healthy Volunteers
No
Interventions
DRUG
Nivolumab
As per product label
Locations (1)
Amsterdam UMC
Amsterdam, Netherlands